Biotechnology - Asia-Pacific, Immunologicals


Popular Filters

Osiris gets second approval for Prochymal, in New Zealand


USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

Astellas in-licenses antibody from Evec; Mitsubishi Tanabe deal with Synageva


Japanese biotech firm Evec has entered a license agreement for one of its fully-human antibodies against…

Asia-PacificAstellas PharmaBiotechnologyEvecImmunologicalsLicensingMitsubishi TanabePharmaceuticalRare diseasesResearchSynageva BioPharma

Back to top